Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors

Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors

US Patent 10183036 · Granted Jan 22, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl ribosid2025
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucl2025
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucl2025
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucl2025
Methods and compositions for treating motor neuron diseases2025
Quinoxalinone compounds, compositions, methods, and kits for increasing genome e2025
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors2025
Methods of preparing nicotinamide riboside and derivatives thereof2025
Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl 2025
Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl 2025
Nicotinamide riboside for use in treating or preventing liver damage2024
Nicotinamide riboside for use in treating or preventing liver damage2024